Clinical Trial Update: Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa [Phase 2]

View source ↗

Summary

Phase 2 trial evaluated the efficacy and safety of oral valproic acid in retinitis pigmentosa and has completed. The sponsor was Seoul National University Hospi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Retinitis Pigmentosa, Retinal Diseases | Phase 2 | Status: COMPLETED